hITGA4 Mouse
Product Name
hITGA4 Mouse
Product ID
C002091
Strain Name
C57BL/6NCya-Itga4em2(hITGA4)/Cya
Backgroud
C57BL/6NCya
Status
When using this mouse strain in a publication, please cite “hITGA4 Mouse (Catalog C002091) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Gene Name
ITGA4
Gene Alias
IA4, CD49D
NCBI ID
Chromosome
Chr 2 (Human)
MGI ID
Datasheet
Strain Description
The ITGA4 gene encodes the integrin α4 subunit, which associates with the integrin β7 subunit (ITGB7) to form the heterodimeric transmembrane protein α4β7, an important member of the integrin family [1,2]. The α4β7 integrin is expressed in a variety of cells and tissues and is highly expressed in immune tissues such as lymph nodes, bone marrow, spleen, and blood, as well as in multiple immune cell types including T lymphocytes, B lymphocytes, monocytes, granulocytes, and natural killer cells [3]. Its primary functions are to mediate cell adhesion and migration, thereby regulating the tissue homing of immune cells and inflammatory responses. By binding to vascular cell adhesion molecule-1 (VCAM-1) and mucosal addressin cell adhesion molecule-1 (MAdCAM-1), α4β7 promotes the migration of lymphocytes to inflamed tissues and gut-associated lymphoid tissues [1,2,4]. Studies have shown that the ITGA4 gene is closely linked to the pathogenesis and progression of multiple diseases, including autoimmune disorders such as inflammatory bowel disease (IBD), Crohn’s disease, ulcerative colitis, and multiple sclerosis (MS) [1,2,5]. Furthermore, high expression of ITGA4 in gastric cancer is associated with poor prognosis, cell proliferation and migration, as well as immune infiltration; its downregulation inhibits migration and promotes apoptosis [3]. Given the critical role of α4β7 integrin in inflammation and immune responses, targeting α4β7 has become an important research direction for the treatment of inflammatory and autoimmune diseases.
The hITGA4 mouse is a humanized model generated by gene-editing technology. The coding sequences of exon 2 plus partial intron 2 of mouse Itga4 were replaced with Chimeric ITGA4 CDS-WPRE-BGH pA cassette. The murine signal peptide was retained. hITGA4 mice can be used to investigate the pathological mechanisms and therapeutic strategies of inflammatory and autoimmune diseases, as well as for the screening, development, and preclinical efficacy and safety evaluation of ITGA4-targeted drugs.
Reference
De Matos MD, Guimenes BD, Pavani GK, Fernandes GG, Montes GC, Fontes-Dantas FL. ITGA4 genetic variants as a predictor of therapeutic responsivity to autoimmune diseases. Front Pharmacol. 2026;16:1745315.
GeneCards. ITGA4 Gene - GeneCards. Accessed July 28, 2026.
Zhang J, Wang G, Liu J, Tang F, Wang S, Li Y. ITGA4 as a potential prognostic and immunotherapeutic biomarker in human cancer and its clinical significance in gastric cancer: an integrated analysis and validation. Front Oncol. 2025;15:1513622.
Kelly AJ, Long A. Targeting T-cell integrins in autoimmune and inflammatory diseases. Clin Exp Immunol. 2024;215(1):15-26.
Abdel-Magid AF. The Potential of the Alpha4 Beta7 Integrin Inhibitors as Treatment for Inflammatory Bowel Diseases and Related Disorders. ACS Med Chem Lett. 2025;16(11):2185-2187.
Strain Strategy
The coding sequences of exon 2 plus partial intron 2 of mouse Itga4 were replaced with Chimeric ITGA4 CDS-WPRE-BGH pA cassette. The murine signal peptide was retained.
Figure 1. Gene editing strategy of hITGA4 mice.
Application Area
ITGA4-targeted drug screening, development, and preclinical evaluation;
Research on the pathological mechanisms and therapeutic approaches of inflammatory and autoimmune diseases such as inflammatory bowel disease (IBD) and multiple sclerosis (MS).
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
